文献速递心血管MR

心脏MRI整体纵向应变分析在主动脉瓣狭窄中的应用:与左心室重构、心肌纤维化及2年临床结局的比较

Global Longitudinal Strain Analysis Using Cardiac MRI in Aortic Stenosis: Comparison with Left Ventricular Remodeling, Myocardial Fibrosis, and 2-year Clinical Outcomes.
PubMed 文献 · Radiol Cardiothorac Imaging · 2019-10-31

本研究评估心脏MRI特征追踪测量的整体纵向应变(GLS)作为主动脉瓣狭窄左心室失代偿标志物的价值,并与心肌纤维化、症状发展、重构和临床结局进行关联分析。结果显示主动脉瓣狭窄患者GLS较健康对照减低,与T1 mapping纤维化指标中度相关,但区分疾病状态能力差,且不能独立预测临床结局。

要点

  • 主动脉瓣狭窄患者GLS较健康对照减低(-17.6% vs -18.9%,P=0.02)。
  • GLS与T1 mapping纤维化指标(如iECV)中度相关(r=0.43,P<0.0001)。
  • GLS区分疾病状态能力差(AUC 0.60-0.64),未独立预测临床结局。

核心结论

  • GLS与已确立的心肌纤维化标志物相关,但单次GLS测量因疾病状态间重叠且不能超越现有标志物预测临床结局,其广泛应用可能受限。

研究设计与样本

  • 研究纳入主动脉瓣狭窄患者159例和健康对照41例,采用心脏MRI特征追踪评估GLS、T1 mapping评估弥漫性纤维化、晚期钆增强评估替代性纤维化,前瞻性随访主要终点为全因死亡。

关键影像表现/征象

  • 主动脉瓣狭窄患者GLS较健康对照减低(-17.6%±3.1 vs -18.9%±2.6,P=0.02)。
  • GLS与主动脉瓣狭窄严重程度(Vmax)呈弱相关(r=0.24,P=0.0005)。
  • GLS与T1 mapping心肌纤维化指标(如iECV)呈中度相关(r=0.43,P<0.0001)。
  • 壁内纤维化患者GLS较健康对照减低(P<0.001),但与心肌梗死患者相似(P=0.25)。

诊断标准与关键数值

  • GLS区分健康对照与患者的AUC为0.60。
  • GLS区分有无纤维化的AUC为0.63。
  • GLS区分症状严重程度(左心室失代偿)的AUC为0.64。
  • 校正分析中,GLS与总心肌纤维化负荷(iECV)和射血分数相关(均P<0.001)。

临床应用与阅片要点

  • GLS与心肌纤维化标志物相关,但单次测量区分疾病状态能力有限。
  • GLS未独立预测临床结局,其超越现有标志物的预测价值未获证实。

局限性

  • GLS区分疾病状态能力差(AUC 0.60-0.64)。
  • GLS未能独立预测临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To use global longitudinal strain (GLS) as a marker of left ventricular decompensation in aortic stenosis and to investigate the relationship of GLS measured with cardiac MRI with markers of myocardial fibrosis, symptom development, remodeling, and clinical outcomes.

MATERIALS AND METHODS: Patients with aortic stenosis and healthy control subjects were assessed. GLS was assessed by using cardiac MRI feature tracking, diffuse fibrosis by T1 mapping, and replacement fibrosis using late gadolinium enhancement. Follow-up was prospective for the primary endpoint of all-cause mortality.

RESULTS: GLS was reduced in aortic stenosis (n = 159) compared with control subjects (n = 41) (-17.6% ± 3.1 [standard deviation] vs -18.9% ± 2.6, P = .02). GLS demonstrated weak associations with aortic stenosis severity (Vmax; r = 0.24, P = .0005) but showed moderate correlation with T1 mapping measures of myocardial fibrosis (eg, indexed extracellular volume [iECV]; r = 0.43, P < .0001). Moreover, GLS was reduced in patients with midwall fibrosis compared with control subjects (P < .001), although values were similar to those of patients with myocardial infarction (P = .25). In adjusted analyses, GLS was associated with total myocardial fibrosis burden (iECV) and ejection fraction (both P < .001). GLS offered poor discrimination between disease states, inability to distinguish between control subjects and patients (area under the curve [AUC], 0.60), presence or absence of fibrosis (AUC, 0.63), or symptomatic severity (left ventricular decompensation AUC, 0.64). At follow-up (median, 1466 days), 21 patients died. GLS did not independently predict clinical outcomes.

CONCLUSION: GLS correlates with established markers of myocardial fibrosis. However, widespread utility of single GLS measurements may be limited by overlap between disease states and its inability to predict clinical outcomes beyond current established markers.© RSNA, 2019Supplemental material is available for this article.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Spath NB, Gomez M, Everett RJ, et al. Global Longitudinal Strain Analysis Using Cardiac MRI in Aortic Stenosis: Comparison with Left Ventricular Remodeling, Myocardial Fibrosis, and 2-year Clinical Outcomes. Radiol Cardiothorac Imaging. 2019. PMID: 33778518. doi:10.1148/ryct.2019190027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。